Home > Research > Researchers > Professor David Allsop > Publications

Research

Professor David Allsop

Formerly at Lancaster University

51 - 75 out of 154Page size: 25
RSS feed of this list
  1. Published

    Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies

    Foulds, P., Yokota, O., Thurston, A., Davidson, Y., Ahmed, Z., Holton, J., Thompson, J. C., Akiyama, H., Arai, T., Hasegawa, M., Gerhard, A., Allsop, D. & Mann, D. M. A., 01/2012, In: Neurobiology of Disease. 45, 1, p. 188-195 8 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  2. Published

    TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer's disease and frontotemporal lobar degeneration

    Foulds, P., McAuley, E., Gibbons, L., Davidson, Y., Pickering-Brown, S. M., Neary, D., Snowden, J. S., Allsop, D. & Mann, D. M. A., 2008, In: Acta Neuropathologica. 116, 2, p. 141-146 6 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  3. Published

    Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease

    Foulds, P., Mitchell, J. D., Parker, A., Turner, R., Green, G., Diggle, P., Hasegawa, M., Taylor, M., Mann, D. & Allsop, D., 2011, In: The FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 25, 12, p. 4127-4137 11 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  4. Published

    Phosphorylated α-synuclein as a potential biomarker for Parkinson's disease (Editorial)

    Foulds, P., Mann, D. & Allsop, D., 2012, In: Expert Review of Molecular Diagnostics. 12, 2, p. 115-117 3 p.

    Research output: Contribution to Journal/Magazine › Editorial

  5. Published

    A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson’s disease

    Foulds, P., Diggle, P., Mitchell, J. D., Parker, A., Hasegawa, M., Masuda-Suzukake, M., Mann, D. M. A. & Allsop, D., 29/08/2013, In: Scientific Reports. 3, 6 p., 2540.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  6. Published

    High-molecular-weight β-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients

    Fukumoto, H., Tokuda, T., Kasai, T., Ishigami, N., Hidaka, H., Kondo, M., Allsop, D. & Nakagawa, M., 2010, In: The FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 24, 8, p. 2716-2726 11 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  7. Published

    Plasma amyloid-β concentrations in Alzheimer's disease : an alternative hypothesis.

    Fullwood, N. J., Hayashi, Y. & Allsop, D., 12/2006, In: Lancet Neurology. 5, 12, p. 1000-1001 2 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  8. Published

    Characterisation of peptidyl boronic acid inhibitors of mammalian 20S and 26S proteasomes and their inhibition of proteasomes in cultured cells

    Gardner, R. C., Assinder, S. J., Christie, G., Mason, G. G. F., Markwell, R., Wadsworth, H., McLaughlin, M., King, R., Chabot-Fletcher, M. C., Breton, J., Allsop, D. & Rivett, A. J., 2000, In: Biochemical Journal. 346, p. 447-454 8 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  9. Published

    Quantification of βA4 protein deposition in the medial temporal lobe: a comparison of Alzheimer's disease and senile dementia of the Lewy body type

    Gentleman, S. M., Williams, B., Royston, M. C., Jagoe, R., Clinton, J., Perry, R. H., Ince, P. G., Allsop, D., Polak, J. M. & Roberts, G. W., 3/08/1992, In: Neuroscience Letters. 142, 1, p. 9-12 4 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  10. Published

    Quantitative differences in the deposition of βA4 protein in the sulci and gyri of frontal and temporal isocortex in Alzheimer's disease

    Gentleman, S. M., Allsop, D., Bruton, C. J., Jagoe, R., Polak, J. M. & Roberts, G. W., 17/02/1992, In: Neuroscience Letters. 136, 1, p. 27-30 4 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  11. Published

    β(A4)-amyloid protein and parkinsonian dementia complex of Guam

    Gentleman, S. M., Perl, D., Allsop, D., Clinton, J., Royston, M. C. & Roberts, G. W., 5/01/1991, In: Lancet. 337, 8732, p. 55-56 2 p.

    Research output: Contribution to Journal/Magazine › Letter › peer-review

  12. Published

    A demonstration of the advantages of immunostaining in the quantification of amyloid plaque deposits

    Gentleman, S. M., Bruton, C., Allsop, D., Lewis, S. J., Polak, J. M. & Roberts, G. W., 1989, In: Histochemistry. 92, 4, p. 355-358 4 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  13. Published

    Induction of cellular oxidative stress by the β-amyloid peptide involved in Alzheimer's disease.

    Gibson, G. L., Allsop, D. & Austen, B. M., 2004, In: Protein and Peptide Letters. 11, 3, p. 257-270 14 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  14. Published

    Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer’s Aβ peptide

    Gregori, M., Taylor, M. N., Salvati, E., Re, F., Mancini, S., Balducci, C., Forloni, G., Zambelli, V., Sesana, S., Michael, M., Michail, C., Kolosov, O. V., Tinker-Mill, C. L., Sherer, M., Harris, S., Fullwood, N. J., Masserini, M. & Allsop, D., 02/2017, In: Nanomedicine: Nanotechnology, Biology, and Medicine. 13, 2, p. 723-732 10 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  15. Published

    Nanoscale SPM characterisation of nacre aragonite plates and synthetic human amyloid fibres

    Grishin, I., Tinker, C., Allsop, D., Robson, A. & Kolosov, O., 2012, NSTI-Nanotech 2012. Santa Clara, USA: CRC PRESS-TAYLOR & FRANCIS GROUP, Vol. 1. p. 110-113 4 p.

    Research output: Contribution in Book/Report/Proceedings - With ISBN/ISSN › Conference contribution/Paper › peer-review

  16. Published

    Variation in the concentration and regional distribution of magnetic nanoparticles in human brains, with and without Alzheimer’s disease, from the UK

    Hammond, J., Maher, B., Ahmed, I. & Allsop, D., 30/04/2021, In: Scientific Reports. 11, 13 p., 9363.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  17. Published

    Oxidative Stress, Cytotoxic and Inflammatory Effects of Urban Ultrafine Road-Deposited Dust from the UK and Mexico in Human Epithelial Lung (Calu-3) Cells

    Hammond, J., Maher, B. A., Gonet, T., Bautista, F. & Allsop, D., 14/09/2022, In: Antioxidants. 11, 9, 18 p., 1814.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  18. Published

    Amyloid deposition as the central event in the aetiology of Alzheimer's disease

    Hardy, J. & Allsop, D., 1991, In: Trends in Pharmacological Sciences. 12, 10, p. 383-388 6 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  19. Published

    Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides

    Hartmann, T., Bieger, S. C., Brühl, B., Tienari, P. J., Ida, N., Allsop, D., Roberts, G. W., Masters, C. L., Dotti, C. G., Unsicker, K. & Beyreuther, K., 09/1997, In: Nature Medicine. 3, 9, p. 1016-1020 5 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  20. Published

    The biology and molecular neuropathology of β-amyloid protein.

    Howlett, D. R., Allsop, D. & Karran, E. H., 2001, Neurobiology of Alzheimer's disease . Dawbarn, D. & Allen, S. J. (eds.). 2nd ed. ed. Oxford: Oxford University Press, p. 75-102 28 p.

    Research output: Contribution in Book/Report/Proceedings - With ISBN/ISSN › Chapter

  21. Published

    Biological activity associated with a high molecular weight form of β-amyloid.

    Howlett, D. R., Ward, R. V., Bresciani, L., Jennings, K. H., Christie, G., Allsop, D., Gray, C. W. & Karran, E. H., 1999, In: Alzheimer's Reports. 2, p. 171-177 7 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  22. Published

    Mechanism of cerebral amyloidosis in Alzheimer's disease

    Howlett, D. R., James, S., Allsop, D. & Roberts, G. W., 1996, Neurobiology of Alzheimer's disease. Dawbarn, D. & Allen, S. J. (eds.). Oxford: BIOS Scientific Publishers, p. 46-59 14 p.

    Research output: Contribution in Book/Report/Proceedings - With ISBN/ISSN › Chapter

  23. Published

    Variability of β-amyloid protein deposited lesions in Down's syndrome brains

    Ikeda, S., Tokuda, T., Yanagisawa, N., Kametani, F., Ohshima, T. & Allsop, D., 1994, In: The Tohoku Journal of Experimental Medicine. 174, 3, p. 189-198 10 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  24. Published

    Gerstmann-Sträussler-Scheinker disease showing β-protein type cerebellar and cerebral amyloid angiopathy

    Ikeda, S. I., Yanagisawa, N., Allsop, D. & Glenner, G. G., 09/1994, In: Acta Neuropathologica. 88, 3, p. 262-266 5 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

  25. Published

    Early senile plaques in Alzheimer's disease demonstrated by histochemistry, immunocytochemistry, and electron microscopy

    Ikeda, S., Yanagisawa, N., Allsop, D. & Glenner, G. G., 12/1990, In: Human Pathology. 21, 12, p. 1221-1226 6 p.

    Research output: Contribution to Journal/Magazine › Journal article › peer-review

Previous 1 2 3 4 5 6 7 Next

Back to top